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TAP-taggingThe Rev protein of HIV-1 is essential for HIV-1 proliferation due to its role in exporting viral RNA from the
nucleus. We used a modiﬁed version of tandem afﬁnity puriﬁcation (TAP) tagging to identify proteins
interacting with HIV-1 Rev in human cells and discovered a prominent interaction between Rev and
nucleosome assembly protein 1 (Nap1). This interaction was also observed by speciﬁc retention of Nap1 from
human cell lysates on a Rev afﬁnity column. Nap1 was found to bind Rev through the Rev arginine-rich
domain and altered the oligomerization state of Rev in vitro. Overexpression of Nap1 stimulated the ability of
Rev to export RNA, reduced the nucleolar localization of Rev, and affected Rev nuclear import rates. The
results suggest that Nap-1 may inﬂuence Rev function by increasing the availability of Rev.
© 2009 Elsevier Inc. All rights reserved.Introduction
Control of gene expression, either at the transcriptional or post-
transcriptional level, plays a central role in the lifecycle of HIV-1,
permitting the virus to establish latent infection and evade the host
immune response. Of the six auxilliary proteins of the virus, two, Tat
and Rev, have been found to be absolutely essential for virus
replication both in vivo and in vitro; Tat acting at the transcriptional
level to increase production of all viral RNAs and Rev, acting at the
level of RNA export, to facilitate expression of the HIV-1 structuralenetics, University of Toronto,
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ll rights reserved.proteins as well as Vif, Vpr, and Vpu (Cullen, 1998). The need for Rev is
a product of the complex pattern of RNA processing used by HIV-1 to
permit synthesis of the complete set of encoded proteins. A single,
9 kb transcript is generated from the integrated provirus that is
processed into over 30 differentmRNAs by alternative splicing that fall
into three size classes: the unspliced 9 kb RNA encoding Gag and
Gagpol, the singly spliced 4 kb RNAs that code for Vif, Vpr, Vpu and
Env, and the 2 kb class of viral RNAs used to express Tat, Rev and Nef
(Cullen,1998). Rev is required to overcome control mechanisms of the
host cell which prevent export to the cytoplasm of incompletely
spliced RNAs. In the absence of Rev, although all HIV-1 RNAs are
generated, only the fully spliced, 2 kb viral RNAs are observed to
accumulate in the cytoplasm, the 9 kb and 4 kb HIV-1 RNAs being
sequestered in the nucleus (Cullen, 1998).
Rev function requires two activities; interaction with the Rev-
response element (RRE) present with the 9 kb and 4 kb viral RNAs via
the arginine-rich motif in the amino terminus of the protein and a
nuclear export signal (NES) within the carboxy terminus that
mediates interaction with the nuclear export apparatus of the cell
(Hope, 1999; Pollard and Malim, 1998). Rev-mediated export of viral
RNA requires interaction via the NES with Exportin-1/Crm-1 in a
RanGTP dependent manner. Crm-1 then docks the complex to the
nuclear pore through interactionwith the nucleoporins. Once released
into the cytoplasm, RanGTP is hydrolyzed to RanGDP by the action of
RanGAP and RanBP-1 which destabilizes the Rev–Crm-1 interaction.
Fig. 1. In vivo protein interactions of SPA-tagged Rev. (A) Schematic representation of
Rev showing the regions important for nuclear and nucleolar localization (NLS/NoLS),
RNA binding (RNA), oligomerization and nuclear export (NES). The sequences of Rev
mutants Δ41–45, Δ45–51, M10 and R84 are also indicated. (B) and (C) SPA-tagged Rev
or the indicated Rev mutants were isolated from 293 cells on FLAG antibody and
calmodulin columns. Proteins eluted from the calmodulin column with EDTA (E) and
SDS (S) were analysed by SDS-PAGE and silver staining and bands were identiﬁed by
MALDI-ToF. Results in the presence (+B) and absence (−B) of benzonase are shown for
Rev in A (all others are in the absence of benzonase). Molecular weight markers (M) are
also shown. The band running at 40 kDa in A is nucleophosmin.
Fig. 2. Cellular protein interactions with a Rev afﬁnity column. Equal amounts of HeLa
cell lysates were passed through micro-afﬁnity columns (40 μl) containing increasing
amounts of puriﬁed Rev or through a negative control column lacking Rev. After
washing, bound proteins were eluted in high salt and analysed by SDS-PAGE, silver
staining and MALDI-ToF mass spectrometry.
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nucleus through interaction with importin β via the nuclear localiza-
tion signal within the arginine-rich motif.
Although the Rev–Crm-1 interaction plays a central role in Rev
activity, subsequent studies have identiﬁed a range of host factors
that are able to positively or negatively modulate Rev function.
Examples include hRip1, Sam68, DDX1 and DDX3, depletion of
which result in a loss of Rev activity (Fang et al., 2004; Modem et
al., 2005; Reddy et al., 1999; Sanchez-Velas et al., 2004; Soros et al.,
2001; Yedavalli et al., 2004). To gain further insight into the cellular
proteins that are utilized by Rev in conducting its essential function
for HIV infection, we have used a derivative of the tandem afﬁnity
puriﬁcation tagging method (SPA-tagging) to proﬁle stable proteininteractions with Rev in human cells (Zeghouf et al., 2004), as well
as an afﬁnity column method to identify in vitro interactions with
cell extracts. Both methods revealed a very prominent interaction
with the nucleosome assembly protein, Nap1. Biochemical and
functional analyses indicate that Rev and Nap1 form stable
stoichiometric complexes that affect the multimerization, sub-
nuclear localization and functional activity of Rev.
Results
Protein interaction proﬁling with Rev
To objectively assess cellular protein interactions with Rev, we
expressed Rev in human cells fused at the C-terminus to a sequential
peptide afﬁnity (SPA) tag, which consists of a triple FLAG sequence
and a calmodulin binding peptide (CBP) separated by a TEV protease
cleavage site. SPA-Rev was then isolated from the cellular extracts on a
FLAG antibody column, eluted by TEV cleavage, bound to a calmodulin
column and eluted ﬁrst with EDTA and subsequently with SDS. This
method has been used previously to isolate stable functional
complexes from human cells (Zeghouf et al., 2004) and is very similar
to the TAP (tandem afﬁnity puriﬁcation)-tagging method that has
been used to uncover stable interactions of the Epstein–Barr virus
EBNA1 protein, RNA polymerase II andminichromosomemaintenance
proteins in human cells (Holowaty et al., 2003; Jeronimo et al., 2004;
Sakwe et al., 2007). Using this method, we consistently isolated Rev in
complex with one cellular protein, which was identiﬁed by mass
spectrometry as the nucleosome assembly protein, Nap1. A proteolytic
fragment of Nap1 was also consistently isolated as indicated by the
double band in Fig. 1. The intensity of the Rev and Nap1 bands was
suggestive of a stoichiometric interaction. Two other cellular proteins
were sometimes, but not always, detected in these experiments;
nucleophosmin/B23 (band at approximately 40 kDa in Fig. 1B) and
cullin 4B (co-migrates with Nap1).
To investigate the possibility that Nap1 and Rev may be tethered
through nucleic acid, the experiment was also conducted in the
presence of benzonase to digest any RNA and DNA in the sample (Fig.
1B). This treatment had no effect on the Rev–Nap1 interaction,
indicating that this interaction is direct. To determine whether Nap1
interacted with a functionally important region of Rev, we repeated
the protein interaction assay using SPA-tagged Rev mutants shown in
Fig. 3. Size exclusion chromatography of Rev, Nap1 and Rev–Nap1 complexes puriﬁed
from insect cells. Nap1 (A) and Rev (B) were expressed individually and together (C)
from baculoviruses and puriﬁed as described in Materials and methods. The puriﬁed
proteins were analysed on a Superdex SD200 gel ﬁltration column in an identical
manner. Equal volume fractions were collected and analysed by SDS-PAGE and
Coomassie staining. An aliquot of the protein loaded (L) and molecular weight markers
(M) are also shown.
Fig. 4. Size exclusion chromatography of Rev and Nap1 puriﬁed from E. coli. Puriﬁed
Nap1 (A) and Rev (B) expressed in E. coli were analysed on a Sephadex S200 gel
ﬁltration column. Nap1 and Rev were also combined in 1:1 (C) and 2:1 (D) ratios then
analysed on the gel ﬁltration column in an identical manner. Tracings from the column
proﬁles are shown; no other protein peaks were detected. Inset gels show the column
fractions corresponding to the peak between the dotted lines.
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sequence (mutant M10) or C-terminal residues 84–116 (mutant R84)
retained the ability to bind Nap1 (Fig. 1C), whereas no Nap1 was
detected when the assay was conducted with Rev mutants Δ41–45
and Δ45–51 (Figs. 1B and C). These Rev mutants lack sequences
important for the nuclear import, multimerization and nucleolar
localization of Rev, suggesting that Nap1 might affect any or all of
these processes (Hope, 1999; Pollard and Malim, 1998).
An afﬁnity columnmethod was used as a second objective method
to proﬁle cellular protein interactions with Rev. In these experiments,
Rev was coupled to a ﬁxed amount of column resin at increasing
concentrations, then identical aliquots of HeLa whole cell lysate were
applied to each Rev column. When the cellular proteins retained on
the columns were eluted and identiﬁed by mass spectroscopy, by far
the most prevalent interaction seen was with Nap1 (Fig. 2). As for the
SPA-tagging experiments, Nap1 was identiﬁed in two bands corre-
sponding to full-length and truncated forms. The recovered amount of
both bands increased with the concentration of Rev on the column,
consistent with a speciﬁc protein interaction. Recovery of Nap1 on the
Rev column was not affected by pre-incubation of the HeLa lysates
with DNaseI and RNaseA, indicating that the Rev–Nap1 interaction is
not mediated by nucleic acid (data not shown; nuclease digestion step
was included in Fig. 2).
Nap1 affects Rev multimerization
To further investigate the signiﬁcance of the Rev–Nap1 interaction,
we conducted gel ﬁltration analyses of Rev–Nap1 complexes formed
in two different ways. In the ﬁrst set of experiments, Rev and Nap1
were expressed individually and together in insect cells from
baculoviruses. The expressed proteins were then puriﬁed and
analyzed by size exclusion chromatography. Based on the elutionproﬁle (peak elution volume of 156 ml; fractions 11–14), native Nap1
was estimated to be 230 kDa in size, indicating that the 45 kDa Nap1
monomers interacted to form stable complexes (Fig. 3A). Rev
expressed on its own formed large aggregates that eluted in the
void volume of the column (fractions 1–4; Fig. 3B). However, when
Rev was co-expressed with Nap1, large Rev aggregates were not
observed; rather Rev co-migrated with Nap1 forming a discreet peak
of a similar size to Nap1 alone (Fig. 3C).
In a second set of experiments, Rev and Nap1 were individually
expressed in Escherichia coli and puriﬁed, then were analyzed by gel
ﬁltration before and after combining the two proteins. Consistent with
theﬁrst experiment, on their own,Nap1migratedas adiscreet complex
approximately 200 kDa in size (Fig. 4A) and Rev behaved as a large
aggregate recovered in the void volume (Fig. 4B). However, when Rev
was incubated with equimolar amounts of puriﬁed Nap1, the Rev peak
in the void volume shifted to the position of native Nap1 (Figs. 4C and
D). Thus the results from both sets of experiments conﬁrm the stable
Fig. 5. The subcellular distribution of SPA-tagged Rev and untagged Rev with and
without Nap1. (A) HeLa cells transfected with constructs expressing either SPA-tagged
Rev or untagged Rev were stained with anti-Rev antibody. (B) HeLa cells were co-
transfected with a Rev-expression construct and either a plasmid expressing myc-
tagged Nap1 or the empty plasmid, then stained with antibodies against Rev and myc.
(C) HeLa cells were stained for the endogenous nucleolar protein EBP2 after
transfection with a plasmid expressing myc-tagged Nap1 or the empty plasmid.
Fig. 6. Functional assay of SPA-tagged Rev. The ability of SPA-tagged Rev to export
unspliced RNA was compared to untagged Rev (+Rev) and no Rev (−Rev) using the
CAT assay described in Materials and methods. Results are shown from both HeLa and
293 cells.
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Nap1 binding limits the self-association of Rev.
Effect of Nap1 on Rev function
Having determined that Rev and Nap1 physically interact, we
sought to determine the functional effects of this interaction. First, we
investigated the functionality and localization of SPA-tagged Rev to
ensure that the tag had not disrupted Rev's function and cellular
localization. SPA-tagged Rev expressed in HeLa cells was found to be
indistinguishable from wildtype Rev, giving largely nucleolar staining(Fig. 5A). The ability of SPA-Rev to export unspliced RNA was then
tested in comparison towild type Rev in bothHeLa and 293 cells, using
a CAT-based reporter assay described previously (Hope et al., 1990). In
both cell types, SPA-Rev was consistently found to induce expression
from unspliced RNAwith a similar efﬁciency as untagged Rev (Fig. 6).
The functional effect of the Rev–Nap1 interaction was investigated
by overexpression of Nap1 and measuring effects on the ability of Rev
to export unspliced RNA. The effect of Nap1 overexpressionwas tested
by co-transfecting HeLa cells and U2OS cells with a plasmid
expressing a dexamethasone-inducible Rev gene (Hope et al., 1990),
a Rev-dependent CAT reporter plasmid and a plasmid that constitu-
tively expresses myc-tagged Nap1 or a negative control plasmid
lacking Nap1 expression. Western blots conﬁrmed the overexpression
of Nap1 relative to endogenous levels (Fig. 7A) and showed that Nap1
overexpression had no signiﬁcant effect on the levels of Rev (Fig. 7B).
Rev expression was then induced by the addition of dexamethasone
and the export of unspliced RNA detected by CAT assay. Nap1
overexpression was consistently found to stimulate Rev-dependent
expression by approximately 2-fold in both cell lines (Figs. 7C and D).
In HeLa cells, assays were also performed inwhich the Rev-dependent
CAT reporter plasmid was replaced by a Rev-independent SEAP
reporter plasmid in order to detect any nonspeciﬁc effects of Nap1
overexpression on gene expression. However Nap1 overexpression
was not observed to affect SEAP expression (Fig. 7D). For the assays
performed in U2OS cells, the SEAP reporter plasmid was co-
transfected with the Rev-dependent CAT reporter and Nap1 effects
on both plasmids were measured. Consistent with the results in HeLa
cells, only CAT expression was affected by Nap1 overexpression, and
the CAT results shown in Fig. 7C have been normalized to SEAP
expression levels. We have also compared total cellular CAT mRNA
levels (by quantitative PCR) with and without Nap1 overexpression
and found these to be unchanged by Nap1, indicating that changes in
CAT expression are not occurring at the transcriptional level (data not
Fig. 7. Effects of Nap1 overexpression on Rev function. (A and C) U2OS cells were co-
transfected with a Rev-dependent CAT reporter, a Rev-independent SEAP reporter, RSV
RevGR and either CMVpA (control) or CMVmycNap1 (Nap1). 48 h post-transfection, the
medium was replaced with (+Rev) or without (−Rev) dexamethasone to induce Rev
expression. One day later, cells were harvested and analyzed for changes in Nap1
expression byWestern blotting (A) or for CAT and SEAP expression and CAT levels were
normalized to SEAP levels for each sample (C). Asterisks indicate values determined to
be statistically signiﬁcant (pb .01) from samples treated with Rev alone (+Rev,
−Nap1). (B and D) The same experiment as in U2OS cells except that HeLa cells were
used. In this case, transfections included either the Rev-dependent CAT reporter (gray
bars) or the Rev-independent SEAP reporter (black bars) and CAT and SEAP results are
shown separately.
Fig. 8. Effects of Nap1 overexpression on Rev nuclear import. (A) To monitor effects of
Nap1 depletion or overexpression on Rev nuclear import, U2OS cells were transfected
with a plasmid expressing RevGR–GFP in the presence (+Nap1) or absence (−Nap1)
of a plasmid expressing myc-tagged Nap1. Cells were then treated with dexamethasone
(+dex) to induce Rev relocalization into the nucleus, or left untreated (−dex). Rev
localization was determined by detection of GFP and recombinant Nap1 was detected
by staining with anti-myc antibody. (B) To examine effects of Nap1 overexpression on
Rev import, cells were transfected with either CMVmyc or CMV mycNap1, prior to
inducing Rev relocalization with dexamethasone. Cells were scored for Rev localization
being primarily cytoplasmic (NbC), nuclear/nucleolar (NNC), or whole cell staining
(N=C). Results for multiple independent assays (NN3) are shown in the absence of
steroid addition (t=0) and 30 min after dexamethasone addition (t=30). Asterisks
denote values determined to be statistically signiﬁcant (pb0.01) from control samples.
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function using the CAT reporter assay, but did not observe a signiﬁcant
effect on Rev function (data not shown). However Western blots
showed incomplete down regulation of Nap1 which complicates
interpretation of these results (data not shown).
Consistent with the increase in Rev function, subsequent analysis
of the effect of Nap1 overexpression on Rev subcellular distribution
revealed changes (Fig. 5B). Despite its functional roles in the nucleus,
the majority of endogenous Nap1 is known to be cytoplasmic in G1
and G2 phases of the cell cycle (Zlatanova, Seebart, and Tomschik,
2007) and, consistent with these reports, overexpression of Nap1 also
resulted in its cytoplasmic accumulation. However, upon Nap1overexpression, Rev staining changed from being predominately
nucleolar to a more uniform staining throughout the nucleus (Fig.
5B), which may account for the stimulation of Rev activity by Nap1
overexpression. The effect of Nap 1 on Rev was not due to a general
disruption of the nucleolus by Nap 1 overexpression, as the
localization of the cellular nucleolar protein EBP2 was not affected
by this treatment (Fig. 5C).
Effects of Nap1 modulation on Rev import
The observation that Nap1 overexpression had a consistent effect
on Rev subcellular distribution and function led us to investigate its
capacity to modulate Rev movement between the nucleus and
cytoplasm. To facilitate these studies, we made use of a previously
described Rev–glucocorticoid receptor (GR) fusion construct (Hope et
al., 1990), but, in this instance, the protein was fused to GFP to permit
its direct detection. Fusion of Rev to GR anchors the protein in the
cytoplasm via interaction with hsp90. Addition of dexamethasone
induces a conformational change in the GR domain, disrupting binding
to hsp90 and freeing the protein to translocate into the nucleus. As
shown in Fig. 8A, in the absence of dexamethasone, RevGR–GFP is
localized exclusively to the cytoplasm. However, upon addition of
dexamethasone, the protein rapidly relocalizes to the nucleus.
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import, cells were transfected with RevGR–GFP and Nap1 expression
plasmid or with RevGR–GFP and siRNA against Nap1. Rev import was
then analyzed by monitoring changes in subcellular distribution of
RevGR–GFP at various times (0–30 min) post-dexamethasone addi-
tion. In the case of Nap1 depletion, dexamethasone addition caused a
trend to greater accumulation of RevGR–GFP in the nucleus relative to
the same cells treated with negative control siRNA, although
subsequent statistical tests failed to indicate signiﬁcance (data not
shown). In contrast, overexpression of Nap1 was found to shift the
distribution of the RevGR–GFP following dexamethasone addition,
resulting in reduced accumulation in the nucleus and signiﬁcant levels
of the Rev remaining in the cytoplasm (Figs. 8A, B). The results
indicate that Nap1 can modulate the nuclear import of Rev.
Discussion
Using two proteomics approaches to proﬁle cellular protein
interactions with Rev, we have discovered a strong interaction
between Rev and Nap1. This work was conducted as part of a viral
proteomics study where the SPA-tagging approach was applied to 72
different proteins from 5 different viruses. Interactions with Nap1
were not observed with any SPA-tagged proteins other than Rev,
indicating that the Rev–Nap1 interaction is highly speciﬁc. However
the SPA-tagging methodology only detects stable interactions and
therefore would not be expected to detect more transient functional
interactions with Rev such as with Crm1.
Nap1 has a well documented role as a chaperone for histones H2A
and H2B thereby facilitating nucleosome assembly (Ishimi and
Kikuchi, 1991; Ito et al., 1996; McQuibban, Commisso-Cappelli, and
Lewis, 1998; Walter et al., 1995). Nap1 also contributes to chromatin
remodeling, at least in part through interactions with NURF and ACF,
and activates transcription through interactions with the p300/CBP
histone acetyl transferase (Okuwaki et al., 2005; Rehtanz et al., 2004;
Shikama et al., 2000; Zlatanova, Seebart, and Tomschik, 2007).
Recently Nap1 has been implicated in linking transcription elongation,
RNA processing and transport through a direct interactionwith Yra1, a
component of the TREX complex known to link transcription to RNA
export (Del Rosario and Pemberton, 2008). In addition, at least in
yeast, Nap1 has an additional role in regulating mitosis through
interactions with cyclin Clb2 and the Gin4 kinase (Altman and
Kellogg, 1997; Kellogg and Murray, 1995).
Our gel ﬁltration analysis of Nap1 expressed in E. coli and insect
cells indicated that the native form of this protein was a complex
just over 200 kDa in size. This suggests that Nap1 was forming
tetramers, although the elongated shape of Nap1 may interfere with
the accurate determination of the complex size (Toth, Mazurkiewicz,
and Rippe, 2005). The tetrameric form would be consistent with
sedimentation equilibrium analyses conducted by McBryant and
Peerson (2004) on puriﬁed yeast Nap1. In this study, Nap1 was
found to form dimers under high salt conditions but formed
209 kDa complexes consistent with tetramerization under more
physiological conditions. Another study using similar sedimentation
equilibrium analyses of yeast Nap1, concluded that Nap1 is in
equilibrium between dimeric and octameric forms in physiological
salt conditions (Toth, Mazurkiewicz, and Rippe, 2005). The recent
structure of yeast Nap1 showed that it crystallized as a dimer,
where dimerization occurred through a long α-helix via an anti-
parallel non-coiled coil interaction (Park and Luger, 2006b).
Our gel ﬁltration analysis of Rev, indicated that puriﬁed Rev formed
large aggregates in solution. The propensity of Rev to multimerize is
well known and cross linking studies performed both in vivo and in
vitro indicate that Rev oligomerizes to form at least tetramers in the
absence of RNA (Zapp et al., 1991). The fact that puriﬁed Rev
(produced in either E. coli or insect cells) migrated in the void volume
of the gel ﬁltration column with molecular weight cut off of 600 kDa,indicates that Rev can form multimers that are considerably larger
than tetramers.
Nap1 was found to decrease multimerization of Rev in vitro and, in
cells, appears to decrease nucleolar localization and stimulate Rev
activity. This is consistent with a model where large Rev aggregates
may be inactive and sequestered to the nucleolus. In keeping with this
model, ﬂuorescence resonance energy transfer studies have indicated
that Rev forms multimers in the nucleolus of living cells (Daelemans
et al., 2004). By disrupting these aggregates, Nap1 may result in more
Rev being available in the nucleus to function in RNA transport. The
Rev sequence (amino acids 41–51) required for Nap1 binding overlaps
with sequences known to mediate Rev multimerization (Thomas et
al., 1998; Zapp et al., 1991), so Nap1 binding to this regionwould likely
physically block Rev homotypic interactions in solution. However, the
fact that Nap1 stimulates Rev function in RNA export indicates that
Nap 1 does not interfere with the assembly of Rev on RNA.
The Rev sequence bound by Nap1 is also known to be important for
nuclear import (Cochrane, Perkins, and Rosen, 1990), and therefore
we tested whether Nap1 affected the nuclear import of Rev. While
most of the functions performed by Nap1 occur in the nucleus, the
main pool of Nap1 resides in the cytoplasm, and Nap1 from yeast,
tobacco and rice has been shown to shuttle between the cytoplasm
and nucleus (Dong et al., 2005; Miyaji-Yamaguchi et al., 2003;
Mosammaparast, Ewart, and Pemberton, 2002). Studies in yeast
showed that, like Rev, the nucleocytoplasmic shuttling of Nap1 is
important for its function and a nuclear export sequence in Nap1 was
identiﬁed (Miyaji-Yamaguchi et al., 2003; Mosammaparast, Ewart,
and Pemberton, 2002). A very similar nuclear export sequence exists
in Nap1 in humans suggesting that human Nap1 is also a shuttling
protein (Miyaji-Yamaguchi et al., 2003). In assays designed tomeasure
effects of Nap1 on the nuclear import of Rev, we observed that Nap1
overexpression reduced Rev import into the nucleus indicating that
Nap1 can interact with Rev in the cytoplasm in addition to the nucleus.
The reduction in Rev nuclear accumulation in the import assays may
be due to the ability of Nap1 to compete with importin β (the import
receptor for Rev) (Truant and Cullen,1999) for the nuclear localization
sequence of Rev. The results suggest a role for Nap1 in regulating the
nuclear uptake of Rev.
Increasing evidence indicates that viruses usurp Nap1 for various
purposes. For example the E2 protein of papillomavirus forms a
ternary complex with Nap1 and p300 that is important for transcrip-
tional activation (Rehtanz et al., 2004). Similarly, the interaction of
Nap1 with HIV-1 Tat was shown to be important for Tat-mediated
activation of the LTR (Vardabasso et al., 2008) and Nap1 binding to the
EBNA1 protein of Epstein–Barr virus was shown to contribute to
EBNA1-mediated transcriptional activation from the EBV FR enhancer
element (Holowaty et al., 2003) (Wang and Frappier, in preparation).
Nap1 also interacts with the Tax protein of HTLV-1 to promote
nucleosome eviction at the HTLV-1 promoter (Sharma and Nyborg,
2008). Similar to our observations with Rev, interactions of Nap1 with
Tat and EBNA1 were found to occur through arginine-rich regions
(Holowaty et al., 2003; Vardabasso et al., 2008).
Cellular proteins Sam68, hRIP, DDX1 and DDX3 have all been
reported to have varied effects on Rev function (Fang et al., 2004;
Modem et al., 2005; Reddy et al., 1999; Sanchez-Velas et al., 2004;
Soros et al., 2001; Yedavalli et al., 2004). The effect of Nap1
overexpression on Rev localization also differs from any effects
reported previously for other Rev binding proteins. The ability of
Nap1 to stimulate Rev function upon overexpression is similar to that
reported for the DDX3 RNA helicase, which was also shown to be
required for Rev function by RNA silencing experiments (Yedavalli et
al., 2004). We have investigated the effect of Nap1 downregulation on
Rev function by siRNA but not seen an obvious effect. This may be due
to the incomplete silencing of Nap1 or due to functional substitution
of Nap1 by the Nap1 homologues, Nap 2, TAF I-α or TAF I-β (Park and
Luger, 2006a).
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import and function suggests that this factor can modulate Rev at
multiple levels. The binding of Nap1 to the nuclear and nucleolar
localization sequences of Rev affects Rev's subcellular localization and
hence its ability to export RNA. It is becoming increasingly clear that
RNA export by Rev involves several cellular proteins, and Nap1 now
joins a growing list of cellular proteins that inﬂuence Rev function.
Materials and methods
In vivo protein interactions
The coding sequences of Rev or Rev mutants M10 (with amino
acids Leu78 and Glu79 converted to Asp78 and Leu79; Malim et al.,
1989), R84 (lacking amino acids 84–116; (Olsen et al., 1991)), Δ41–45
and Δ45–51 (Cochrane, Perkins, and Rosen, 1990) were PCR ampliﬁed
using primers with a 5′ Xho I site and a 3′ Xba I site and cloned
between the Xho I and Xba I sites of pMZS3F (Zeghouf et al., 2004).
The resulting constructs expresses Rev with a C-terminal SPA tag. The
pMZ3F-Rev constructs were used to transfect six 150 mm plates of
HEK 293-T cells by the calcium phosphate method. Cells were
harvested 24 h post-transfection and SPA-tagged Rev was isolated
from cell lysates as previously described on FLAG monoclonal
antibody (M2) and calmodulin columns (Zeghouf et al., 2004).
Proteins bound to the calmodulin column were eluted ﬁrst with
buffer containing 5 mM EDTA and then with 1% SDS. Eluates from the
calmodulin column were analysed by SDS-PAGE and silver staining
and bands were identiﬁed by MALDI-ToF mass spectrometry. When
benzonase was included, it was added to a concentration of 200 U/ml
at the time of cell lysis and just prior to loading onto the FLAG
antibody column.
Puriﬁcation of E. coli-expressed Rev
The Rev coding sequencewas cloned in a modiﬁed pET15b plasmid
and expressed in an BL21(DE3)Gold E. coli fused to an N-terminal
hexahistidine tag. Three 1 L cultures were grown in Terriﬁc Broth
containing 50 μg/ml ampicillin and Rev expressionwas induced by the
addition of 0.5 mM IPTG overnight at 15 °C. Cells were harvested by
centrifugation and resuspended in 45 ml lysis buffer (50 mM Hepes
pH 7.5, 5 mM imidazole, 500 mM NaCl, 5% glycerol, 1.5 mM
benzamidine, 600 μM PMSF), ﬂash frozen and stored at −80 °C.
After thawing at 4 °C, CHAPS (ﬁnal concentration of 5 mg/ml),
benzonase (250 U) and fresh protease inhibitors (ﬁnal concentration
1.5 mM benzamidine, 600 μM PMSF) were added and cell suspensions
were incubated on a rocking platform for 45 min. Lysate were then
clariﬁed by sonication and centrifugation at 30000 ×g for 45 min at
4 °C. The supernatant was passed through a DE-52 column then
loaded onto a 5 ml Ni-NTA superﬂow column (Qiagen), both
equilibrated with 50 mM Hepes pH 7.5, 5 mM imidazole, 500 mM
NaCl, 5% glycerol. The Ni-NTA column was washed with 200 ml of
50mMHepes pH 7.5, 30mM imidazole, 500mMNaCl, 5% glycerol and
bound proteins were eluted by increasing the imidazole concentration
to 150 mM. Eluted protein was then subjected to gel ﬁltration
chromatography on a Superdex SD200 column (Amersham) equili-
brated in 50mMHepes pH 7.5, 500mMNaCl and was recovered in the
void volume. Puriﬁed Rev was quantiﬁed by absorbance at 280 nm
using an extinction coefﬁcient of 6.407 and the yield was approxi-
mately 10 mg per liter of culture.
In vitro protein interactions
Puriﬁed Rev was coupled to Afﬁ-gel 10 resin (Bio-Rad) at a
concentration of 0, 0.25, 0.5, 1 and 2 mg/ml as previously described
(Holowaty et al., 2003). After blocking in ethanolamine, the coupled
resinwas thoroughly washedwith 20mMHepes, 1 MNaCl, 1 mMDTT,1 mM EDTA, 10% glycerol, then with the same buffer containing 0.1 M
NaCl (loading buffer). HeLa whole cell lysates were generated as
described in Holowaty et al. (2003) and dialysed against the loading
buffer. CaCl2 was then added to 4mM and lysates were incubated with
RNase A and DNase I (1.4 μg/mg lysate) for 30 min at room
temperature. 400 μl of the HeLa lysate (at 10 mg/ml) was loaded
onto each 40 μl column of the Afﬁ-gel coupledwith Rev. Columnswere
washedwith 400 μl loading buffer thenwith 160 μl loading buffer plus
1% Triton X-100. Bound proteins were eluted by increasing the NaCl
concentration to 1 M then by the addition of 1% SDS. Eluted proteins
were analyzed by SDS-PAGE and silver staining and identiﬁed by
MALDI-ToF mass spectrometry of excised bands.
Puriﬁcation and gel ﬁltration analyses of baculovirus-produced Rev,
Nap1 and Rev–Nap1 complex
Coding sequences for Rev and Nap1 were cloned into pFastBac,
fused at the N-terminus to a hexahistidine tag. Bacmids were
generated and used to transfect SF-9 insect cells to generate
baculoviruses expressing Rev or Nap1. Baculoviruses expressing Rev
and Nap1 were used to infect 600 ml of High Five insect cells (at
2×106 cells/ml) in HyQ-SFX-Insect serum-free medium (Hyclone),
individually and together. Infected cells were grown in shaker ﬂasks
for 48 h then harvested and resuspended in 150 ml of lysis buffer
containing 0.6% NP-40. Lysates were clariﬁed by sonication and
centrifugation. Supernatants were passed through DE52 columns
packed with 10 g of resin then loaded onto a 2.5 ml Ni-NTA column.
The Ni-NTA columns were washed as described above for E. coli-
produced Rev and protein was eluted with 12.5 ml of the same buffer
containing 300 mM imidazole. EDTA was immediately added to
eluates (1 mM ﬁnal concentration), followed by the addition of DTT to
5 mM. The eluted proteins were dialyzed overnight at 4 °C against
10 mM Hepes pH 7.5, 500 mM NaCl, 5% glycerol, 5 mM CaCl2 in the
presence of 150 U of thrombin in order to cleave the hexahistidine tag
from the protein. The proteins were then ﬂowed through a second Ni-
NTA column to remove any uncut protein that retained the tag. After
the addition of EDTA and DTT as above, protein in the ﬂow-through
fractions was concentrated to 5 ml in a Centricon with 5 kDa
molecular weight cut off, then dialyzed against citrate buffer (10 mM
Hepes, 150 mM NaCl, 25 mM sodium citrate, 5 mM DTT). Each sample
was then applied to a 320 ml Superdex SD200 gel ﬁltration column
(Amersham) equilibrated in citrate buffer. The column was run at
2.5 ml/min and equal volume fractions were collected and analysed
by SDS-PAGE and Coomassie staining.
Gel ﬁltration analysis of E. coli-expressed Rev–Nap1 complexes
Rev was expressed and puriﬁed from E. coli on DE52 and Ni-NTA
columns as described above, then dialyzed against citrate buffer
overnight at 4 °C. Nap1 in pET15b (kindly provided by Jerry Pelletier;
(Rodriguez et al., 1997)) was expressed in BL21(DE3)Gold E. coli,
puriﬁed as for Rev and dialyzed against citrate buffer overnight at 4 °C.
To generate Rev–Nap1 complexes, puriﬁed Nap1 and Rev from the
nickel column eluates were combined in 1:1 and 2:1 (Nap1:Rev)
molar ratios and dialysed against citrate buffer overnight at 4 °C. All
samples were then concentrated to 5 ml in a Centricon and analyzed
on a Superdex SD200 gel ﬁltration column in citrate buffer as
described above for baculovirus-produced proteins.
Rev activity assays
The Nap1 expression vector (CMVmycNap1) was constructed by
PCR ampliﬁcation of Nap1 cDNA (from pET15b/Nap1) using the
primer set 5′-GGG AAG CTT ATG CCA GAC ATT GAC AAC -3′ and 5′-
GGG GGA TCC CTG CTG CTT GCA CTC TGC -3′. The amplicon was
digested with HindIII/BamH1 and cloned into the respective sites in
110 A. Cochrane et al. / Virology 388 (2009) 103–111the CMVmyc3xterm expression vector (Pongoski, Asai, and Cochrane,
2002). To monitor effects of Nap1 on Rev function, HeLa cells were
transfected using calcium phosphate (Kriegler, 1990) with RSV RevGR
(Hope et al., 1990), the Rev-dependent reporter plasmid VCEhygro
(Pongoski, Asai, and Cochrane, 2002), and either CMVpA (Pongoski,
Asai, and Cochrane, 2002) or CMVmycNap1. Twenty-four hours post-
transfection, cells were left as is or treated with 10 μMdexamethasone
for a further 24 h prior to harvesting. CAT assays were performed as
previously described (Gorman, Moffatt, and Howard, 1982). Identical
assays were also performed in which VCEhygro was replaced by CMV
Myc PLAP (Woolaway et al., 2007). CMV Myc PLAP expresses secreted
alkaline phosphatase (SEAP) independently of Rev and was used as a
control of nonspeciﬁc effects of Nap 1 on gene expression. SEAP was
quantiﬁed as previously described (Lin et al., 2008; Woolaway et al.,
2007). To test the activity of the SPA-tagged form of Rev, HeLa or 293
cells were transfected with the Rev-dependent reporter pDM128
(Hope et al., 1990) and CMVpA (empty plasmid), CMV H6Rev
(Pongoski, Asai, and Cochrane, 2002) or pMZ3F-Rev and CAT assays
performed 48 h post-transfection.
For Nap1 overexpression experiments in U2OS cells, U2OS cells
were transfected using polyethyleneimine (PEI; Polysciences, Inc.)
with plasmids CMVmycNap1 or CMVpA (2 μg), RSV RevGR–GFP
(0.2 μg) and reporter constructs pDM128 (0.4 μg) (Hope et al., 1990)
and CMV Myc PLAP (0.2 μg). Rev was induced 48 h after transfection
by addition of dexamethasone to 25 μM. Assays for CAT and SEAPwere
then performed with normalization of the CAT results to SEAP signals.
Western blots were also performed on equal amounts of total protein
(20–30 μg) using monoclonal antibodies against Nap1 (kindly
provided by Yukio Ishimi), and tubulin, followed by peroxidase-
conjugated donkey anti-mouse IgG (Jackson ImmunoResearch). Blots
were developed using Western Lightning Chemiluminescence
Reagent Plus (Perkin Elmer). Due to the lack of antibodies that
recognize Rev in Western blots, the effect of Nap1 on Rev levels was
determined by co-transfecting U2OS cells with a plasmid expressing
FLAG-tagged Rev and either CMVmycNap1 or CMVpA. Rev levels were
then determined in Western blots using anti-FLAG antibody.
Nuclear import assay and immunoﬂuorescence microscopy
To test the effect of Nap1 expression on Rev subcellular localiza-
tion, HeLa cells were transfected with CMV H6Rev alone (Cochrane et
al., 1989), CMVmycNap1 alone, or CMVH6Rev and CMVmycNap1 using
calcium phosphate. Forty-eight hours post-transfection, cells were
ﬁxed and permeabilized. Localization of proteinswas carried out using
rabbit anti-Rev antibody (Pongoski, Asai, and Cochrane, 2002) and
mouse anti-myc (9E10; Invitrogen) antibody followed by incubation
with FITC-conjugated anti-rabbit antibody and Texas Red-conjugated
anti-mouse antibody. Nuclei were detected by staining with DAPI.
Images were collected using a Leica DMR microscope with a cooled
CCD camera at 630× magniﬁcation. The possible effect of Nap1
overexpression on cellular nucleolar proteins was examined by
transfecting HeLa cells with CMVmycNap1 or the parental empty
plasmid and staining ﬁxed cells with polyclonal antibody against EBP2
(Wu, Ceccarelli, and Frappier, 2000).
To monitor effects of Nap1 overexpression on kinetics of Rev
import, U2OS cells were transfected with pRevGR-GFP, CMV PLAP and
either CMVmyc3xterm or CMVmycNAP1. After 24 h, cells were
incubated at 30 °C and import of Rev initiated by addition of
dexamethasone (10 μM). Cells were ﬁxed at various times post
dexamethasone addition and processed for immunoﬂuorescence
localization of Rev (GFP signal) and Nap1 (using anti-myc antibody).
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